Literature DB >> 10652304

Regulation of Pap phase variation. Lrp is sufficient for the establishment of the phase off pap DNA methylation pattern and repression of pap transcription in vitro.

N J Weyand1, D A Low.   

Abstract

The pyelonephritis-associated pili (pap) operon in Escherichia coli is regulated by an epigenetic mechanism involving the formation of specific DNA methylation patterns characteristic of transcriptionally active (phase ON) and inactive (phase OFF) cells. The formation of pap DNA methylation patterns in vivo was previously shown to require the leucine-responsive regulatory protein (Lrp) and DNA adenine methylase (Dam). To monitor the binding of Lrp to pap DNA, an in vitro methylation protection assay was developed. Binding of Lrp to a Dam target site proximal to the papBA promoter (designated GATC(prox)) blocked methylation of this site and specifically repressed transcription. The DNA methylation pattern and transcription state are identical to those observed in vivo in phase OFF cells. To determine if binding of Lrp at GATC(prox) was necessary for repression of papBA transcription, we analyzed a pap mutation (pap-13) that reduced the affinity of Lrp for the GATC(prox) region. Binding of Lrp to pap-13 DNA was shifted to a promoter distal Dam target site (designated GATC(dist)). Lrp blocked methylation of GATC(dist) in the pap-13 mutant, but did not repress papBA transcription. Together, these results show that binding of Lrp to the GATC(prox) region is sufficient for the establishment of the phase OFF DNA methylation pattern and repression of papBA transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652304     DOI: 10.1074/jbc.275.5.3192

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili.

Authors:  D L Hung; T L Raivio; C H Jones; T J Silhavy; S J Hultgren
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  Roles of DNA adenine methylation in regulating bacterial gene expression and virulence.

Authors:  D A Low; N J Weyand; M J Mahan
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Dam- and OxyR-dependent phase variation of agn43: essential elements and evidence for a new role of DNA methylation.

Authors:  Anu Wallecha; Vincent Munster; Jason Correnti; Teresa Chan; Marjan van der Woude
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

Review 4.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  Structure of the Escherichia coli leucine-responsive regulatory protein Lrp reveals a novel octameric assembly.

Authors:  Stephanie de los Rios; John J Perona
Journal:  J Mol Biol       Date:  2006-12-19       Impact factor: 5.469

6.  The CcrM DNA methyltransferase of Agrobacterium tumefaciens is essential, and its activity is cell cycle regulated.

Authors:  L S Kahng; L Shapiro
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

Review 7.  The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes.

Authors:  Yogitha N Srikhanta; Kate L Fox; Michael P Jennings
Journal:  Nat Rev Microbiol       Date:  2010-02-08       Impact factor: 60.633

Review 8.  Programmed heterogeneity: epigenetic mechanisms in bacteria.

Authors:  Josep Casadesús; David A Low
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

9.  Self-perpetuating epigenetic pili switches in bacteria.

Authors:  Aaron Hernday; Margareta Krabbe; Bruce Braaten; David Low
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-29       Impact factor: 11.205

10.  Regulation of P-fimbrial phase variation frequencies in Escherichia coli CFT073.

Authors:  Nicola Holden; Makrina Totsika; Lynn Dixon; Kirsteen Catherwood; David L Gally
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.